ORGANOGENESIS INC.

In News

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® - Ortho Spine News

Ortho Spine News - Apr 29, 2026

Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update - Yahoo Finance

Yahoo Finance - May 20, 2026

Organogenesis (ORGO) AGM 2026 Summary - Quartr

Quartr - Jul 10, 2026

RI skin-maker Organogenesis reports steep Q1 loss amid CMS policy change - The Business Journals

The Business Journals - May 08, 2026

Organogenesis schedules Aug. 6 results call after market close - Stock Titan

Stock Titan - Jul 09, 2026

Organogenesis: Mesmerized By Wound Care Struggles, Upcoming ReNu Blockbuster Overlooked - Seeking Alpha

Seeking Alpha - Jun 15, 2026

FDA accepts Organogenesis’ application for knee osteoarthritis treatment - Investing.com

Investing.com - Jul 06, 2026

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - The Manila Times

The Manila Times - Jul 09, 2026

Organogenesis' Biologics License Application for ReNu Accepted by FDA for Review - Moomoo

Moomoo - Jul 06, 2026

ORGO Forecast — Price Target — Prediction for 2027 - TradingView

TradingView - Jun 26, 2026

Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative

Quiver Quantitative - Dec 23, 2025

Organogenesis (ORGO) Q1 2025 earnings summary - Quartr

Quartr - Jul 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment